A federal judge in New Jersey tossed lawsuits from Johnson & Johnson and Bristol Myers Squibb questioning the constitutionality of the federal government requiring drugmakers to negotiate with ...

U.S. pharmaceutical company Johnson & Johnson (J&J) announced Tuesday it is suing the Department of Health and Human Services (HHS) over Medicare Drug Price Negotiation Program, becoming the latest of ...

Johnson & Johnson (NYSE:JNJ) and Bristol Myers Squibb (NYSE:BMY) have become the latest industry participants to lose legal challenges against the Medicare drug price negotiation program, a major ...

July 18 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block a program that gives the Medicare government health ...

Johnson & Johnson (NYSE:JNJ) has become the latest major drugmaker to sue over provisions under the Inflation Reduction Act that allow the US government to negotiate drug prices for programs such as ...